Valbiotis SA develops products and candidate drugs designed to prevent metabolic diseases. The company was founded on December 2, 2014 and is headquartered in Perigny, France.
The current price of ALVAL is 3.60 EUR — it has increased by 0.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange VALBIOTIS stocks are traded under the ticker ALVAL.
One year price forecast for VALBIOTIS has a max estimate of 11.80 EUR and a min estimate of 9.20 EUR.
Yes, you can track VALBIOTIS financials in yearly and quarterly reports right on TradingView.
Like other stocks, ALVAL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VALBIOTIS stock right from TradingView charts — choose your broker and connect to your account.
ALVAL reached its all-time high on Jun 14, 2017 with the price of 10.55 EUR, and its all-time low was 1.98 EUR and was reached on Dec 5, 2019. See other stocks reaching their highest and lowest prices.
As of Mar 28, 2024, the company has 48.00 employees. See our rating of the largest employees — is VALBIOTIS on this list?